Market Cap 29.18M
Revenue (ttm) 1.27M
Net Income (ttm) -7.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -560.63%
Debt to Equity Ratio 0.02
Volume 476,984
Avg Vol 3,166,354
Day's Range N/A - N/A
Shares Out 79.69M
Stochastic %K 63%
Beta 1.45
Analysts Sell
Price Target $3.88

Company Profile

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease in India, the United States, and Colombia. The company's lead product is IGC-AD1, which is in Phase 2 clinical trial for the treatment of agitation in dementia due to Alzheimer's; and TGR-63, IGC-M3, and LMP that are in pre-clinical stage for the treatment of Alzheimer's disease. It also develops IGC-1A and IGC-1C which are in pre-clinical stage for the treatment of metabolic disor...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 983 0998
Address:
10224 Falls Road, Potomac, United States
Bcscoatings
Bcscoatings Jul. 28 at 11:24 PM
$TNFA a lot of attention coming here👀👀👀🔥🔥. $SMX $QH $IGC
0 · Reply
Tom678
Tom678 Jul. 28 at 8:45 PM
0 · Reply
Bulltrader988
Bulltrader988 Jul. 28 at 6:02 PM
$IGC ...👃👀
0 · Reply
oii
oii Jul. 28 at 11:25 AM
$IGC waiting for the real push
0 · Reply
Bulltrader988
Bulltrader988 Jul. 27 at 6:23 PM
$IGC begin today: "...today announced the presentation of three scientific posters at the 2025 Alzheimer's Association International Conference ("AAIC"), taking place July 27-31 in Toronto, Canada.... We are excited to share our latest AI innovations at AAIC 2025, which underscore IGC's commitment to transforming Alzheimer's care and research", said Ram Mukunda, CEO of IGC Pharma. "Our cutting-edge deep learning techniques are designed to expand access to earlier diagnosis and accelerate the discovery of effective therapeutics by leveraging diverse, real-world datasets. Showcasing this research at the AAIC is a pivotal step as we establish IGC as a leader in applying AI to precision medicine in Alzheimer's, strengthening our scientific foundation and streamlining drug development..." 👃👀
0 · Reply
billionaire128
billionaire128 Jul. 26 at 8:28 PM
$IGC sleeper trade and sleeper play
0 · Reply
Bulltrader988
Bulltrader988 Jul. 26 at 6:43 PM
$IGC next week 👃👀
0 · Reply
Ottersberger
Ottersberger Jul. 25 at 5:37 PM
$IGC hopefully not tooooooooo long 🤑
0 · Reply
Tom678
Tom678 Jul. 25 at 1:51 PM
$IGC holding this gem long too.
1 · Reply
UCIdidmyDD
UCIdidmyDD Jul. 25 at 4:18 AM
$IGC long 50k
0 · Reply
Latest News on IGC
IGC Pharma Welcomes Strategic Investment from Advisors

Apr 24, 2025, 9:30 AM EDT - 3 months ago

IGC Pharma Welcomes Strategic Investment from Advisors


IGC Pharma Reports Third Quarter Fiscal 2025 Results

Feb 18, 2025, 8:30 AM EST - 5 months ago

IGC Pharma Reports Third Quarter Fiscal 2025 Results


IGC Pharma Reports First Quarter Fiscal 2025 Results

Aug 8, 2024, 9:30 PM EDT - 1 year ago

IGC Pharma Reports First Quarter Fiscal 2025 Results


IGC Pharma to Attend BIO International Convention 2024

May 21, 2024, 2:00 PM EDT - 1 year ago

IGC Pharma to Attend BIO International Convention 2024


IGC Pharma Adds Advisor in Artificial Intelligence

Apr 9, 2024, 9:00 AM EDT - 1 year ago

IGC Pharma Adds Advisor in Artificial Intelligence


IGC Pharma Reports Third Quarter Fiscal 2024 Results

Feb 16, 2024, 7:05 PM EST - 1 year ago

IGC Pharma Reports Third Quarter Fiscal 2024 Results


Bcscoatings
Bcscoatings Jul. 28 at 11:24 PM
$TNFA a lot of attention coming here👀👀👀🔥🔥. $SMX $QH $IGC
0 · Reply
Tom678
Tom678 Jul. 28 at 8:45 PM
0 · Reply
Bulltrader988
Bulltrader988 Jul. 28 at 6:02 PM
$IGC ...👃👀
0 · Reply
oii
oii Jul. 28 at 11:25 AM
$IGC waiting for the real push
0 · Reply
Bulltrader988
Bulltrader988 Jul. 27 at 6:23 PM
$IGC begin today: "...today announced the presentation of three scientific posters at the 2025 Alzheimer's Association International Conference ("AAIC"), taking place July 27-31 in Toronto, Canada.... We are excited to share our latest AI innovations at AAIC 2025, which underscore IGC's commitment to transforming Alzheimer's care and research", said Ram Mukunda, CEO of IGC Pharma. "Our cutting-edge deep learning techniques are designed to expand access to earlier diagnosis and accelerate the discovery of effective therapeutics by leveraging diverse, real-world datasets. Showcasing this research at the AAIC is a pivotal step as we establish IGC as a leader in applying AI to precision medicine in Alzheimer's, strengthening our scientific foundation and streamlining drug development..." 👃👀
0 · Reply
billionaire128
billionaire128 Jul. 26 at 8:28 PM
$IGC sleeper trade and sleeper play
0 · Reply
Bulltrader988
Bulltrader988 Jul. 26 at 6:43 PM
$IGC next week 👃👀
0 · Reply
Ottersberger
Ottersberger Jul. 25 at 5:37 PM
$IGC hopefully not tooooooooo long 🤑
0 · Reply
Tom678
Tom678 Jul. 25 at 1:51 PM
$IGC holding this gem long too.
1 · Reply
UCIdidmyDD
UCIdidmyDD Jul. 25 at 4:18 AM
$IGC long 50k
0 · Reply
Bulltrader988
Bulltrader988 Jul. 24 at 6:29 PM
$IGC "...today announced the presentation of three scientific posters at the 2025 Alzheimer’s Association International Conference (“AAIC”), taking place July 27-31 in Toronto, Canada. The poster presentations highlight advancements in the Company’s proprietary artificial intelligence (“AI”) platforms designed to accelerate drug discovery and improve early detection of Alzheimer’s disease, particularly in low-resource settings.... At the AAIC 2025, IGC’s team will present: Poster Number: 108625 Title: Multimodal Interpretable Transformer for AD (MINT-AD) Poster Number: 108631 Title: MINT-AD: Early Prediction of MMSE & CSI-D Scores with AI Poster Number: 108629 Title: AI in the Drug Discovery Pipeline.." 👃👀 https://igcpharma.com/igc-pharma-to-present-advanced-ai-platforms-for-alzheimers-disease-at-the-aaic-2025/
0 · Reply
angel6
angel6 Jul. 24 at 5:13 PM
$IGC give us an actual news like FDA approval
0 · Reply
IGC
IGC Jul. 24 at 4:01 PM
$IGC IGC Pharma will present 3 scientific posters at the Alzheimer's Association® International Conference 2025, highlighting our artificial intelligence achievements in Alzheimer’s research. Our presentations explore how AI can support earlier detection, identify high-value clinical opportunities, and streamline drug discovery for underserved and low-resource populations. Authored by our international research team: • Poster 108629 – Néstor González, Paola Ruiz Puentes, Diego Rodríguez-Soacha, Daniel Andrés Crovo Pérez, Ram Mukunda • Poster 108625 – Paola Ruiz Puentes, Néstor González, Daniel Andrés Crovo Pérez, Maria Catalina Ibañez Piñeres, Pablo Arbelaez, Ram Mukunda • Poster 108631 – Daniel Andrés Crovo Pérez, Paola Ruiz Puentes, Néstor González, Pablo Arbelaez, Ram Mukunda We’re honored to contribute to the world’s largest dementia research forum and to continue advancing innovation in neurodegeneration. Read more: https://igcpharma.com/igc-pharma-to-present-advanced-ai-platforms-for-alzheimers-disease-at-the-aaic-2025/
0 · Reply
oii
oii Jul. 24 at 3:43 PM
$IGC lets move
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 23 at 4:57 PM
$IGC Great piece that accurately captures IGC's current position. So if you want to refresh your understanding of IGC or learn about IGC for the first time, this is essential reading. https://beyondspx.com/article/igc-pharma-revolutionizing-alzheimer-s-diagnostics-and-treatment-with-ai-powered-innovation-nyse-igc
0 · Reply
Lloydclat
Lloydclat Jul. 23 at 4:22 PM
0 · Reply
Bulltrader988
Bulltrader988 Jul. 23 at 1:27 PM
$IGC "...today announced the presentation of three scientific posters at the 2025 Alzheimer's Association International Conference ("AAIC"), taking place July 27-31 in Toronto, Canada. The poster presentations highlight advancements in the Company's proprietary artificial intelligence ("AI") platforms designed to accelerate drug discovery and improve early detection of Alzheimer's disease, particularly in low-resource settings. IGC Pharma's team will be participating in person..." 👃👀 https://www.stocktitan.net/news/IGC/igc-pharma-to-present-advanced-ai-platforms-for-alzheimer-s-disease-i5upvjh8efwt.html
0 · Reply
Tom678
Tom678 Jul. 23 at 1:16 PM
IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025 $IGC amazing news !! Company is growing every day towards success https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-to-present-advanced-ai-platforms-for-alzheimers-disease-at-the-aaic-2025-1051802
0 · Reply
lecorb
lecorb Jul. 23 at 1:11 PM
$IGC IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025 Wednesday, 23 July 2025 09:00 AM
0 · Reply
lecorb
lecorb Jul. 23 at 1:10 PM
$IGC https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-to-present-advanced-ai-platforms-for-alzheimers-disease-at-the-aaic-2025-1051802
0 · Reply
RocketQueen
RocketQueen Jul. 23 at 12:23 PM
$IGC refreshing fundamentals here. I've been following this since 2018. It looks like things are looking up.
0 · Reply
Tom678
Tom678 Jul. 23 at 11:27 AM
0 · Reply